Alpha-Hydroxyetizolam
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | α-Hydroxyetizolam |
| Dependence liability |
Moderate |
| Routes of administration |
Oral, sublingual, rectal |
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Elimination half-life | 8.2 hours |
| Excretion | Kidney |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H15ClN4OS |
| Molar mass | 358.84 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
alpha-Hydroxyetizolam is the pharmacologically active metabolite of etizolam.alpha-Hydroxyetizolam has a half-life of approximately 8.2 hours.
Etizolam's other non-pharmacologically active metabolite in humans is 8-hydroxyetizolam.
See also
External links
| 5-HT1AR agonists | |
|---|---|
| GABAAR PAMs |
|
|
Gabapentinoids |
|
| Antidepressants |
|
|
Sympatholytics |
|
| Others | |
| |
| PAFR |
|
||||
|---|---|---|---|---|---|
| Others |
|
||||
| |||||